Table 2. Gene expression of 20 probe sets associated with disease progression or death due to OSCC, University of Washington Affiliated Medical Centers, 2003–2010.
Probe ID | Gene Symbol | HR* | 95% CI | p-value | Coefficient in the Cox model** | |
225105_at | OCC1 | 1.9 | 1.5 | 2.4 | 4.00E-07 | 0.46727 |
218854_at | SART2 | 3.0 | 1.9 | 4.6 | 5.80E-07 | 0.22577 |
208636_at | ACTN1 | 2.3 | 1.6 | 3.3 | 1.90E-06 | 0.47392 |
212589_at | RRAS2 | 2.5 | 1.7 | 3.8 | 6.80E-06 | 0.61303 |
201474_s_at | ITGA3 | 2.1 | 1.5 | 2.9 | 6.90E-06 | −0.10248 |
201976_s_at | MYO10 | 1.9 | 1.4 | 2.6 | 7.70E-06 | 0.16939 |
204334_at | KLF7 | 2.1 | 1.5 | 2.9 | 2.30E-05 | 0.59466 |
214853_s_at | SHC1 | 2.7 | 1.7 | 4.3 | 6.00E-05 | 0.59933 |
1552277_a_at | MSANTD3 | 2.2 | 1.5 | 3.3 | 6.10E-05 | 0.63538 |
202896_s_at | SIRPA | 2.3 | 1.5 | 3.5 | 6.10E-05 | −0.48287 |
225795_at | C22orf32 | 0.3 | 0.2 | 0.6 | 7.70E-05 | −0.60779 |
202872_at | ATP6V1C1 | 2.6 | 1.6 | 4.2 | 9.00E-05 | 0.44730 |
205122_at | TMEFF1 | 1.5 | 1.2 | 1.8 | 1.00E-04 | −0.16921 |
213139_at | SNAI2 | 2.1 | 1.4 | 3.0 | 1.00E-04 | −0.59571 |
228914_at | MSANTD3-TMEFF1 | 2.2 | 1.4 | 3.3 | 2.30E-04 | −0.29491 |
235492_at | RNF217 | 1.9 | 1.3 | 2.7 | 2.80E-04 | −0.23651 |
221898_at | PDPN | 1.5 | 1.2 | 1.9 | 2.90E-04 | −0.19016 |
202599_s_at | NRIP1 | 1.9 | 1.3 | 2.7 | 3.00E-04 | 0.16372 |
206581_at | BNC1 | 1.7 | 1.3 | 2.3 | 4.80E-04 | −0.25078 |
1558152_at | LOC100131262 | 1.5 | 1.2 | 2.0 | 6.10E-04 | −0.15511 |
Hazard ratio of each gene from Cox regression analysis adjusting for age, sex, tumor stage, and high-risk HPV status.
Cox model incorporating 20 probe sets, used for calculating a risk score.